imfinzi

  1. Newly approved in the EU: Durvalumab (Imfinzi) an immunotherapy for Stage III Lung Cancer

    Read more »
  2. What happens between availability and approval of medicines?

    TimeUnderstand why approval doesn’t necessarily mean availability and what you can do if a medicine is approved, but not available in your country.

    Read more »
  3. 10 Things You Need to Know About Lung Cancer

    In 2015, an estimated 221,200 people in the U.S. will be diagnosed with lung cancer, which is 13 percent of all cancer diagnoses.

    lung cancer knowledge

    Read more »
  4. Why is there often a substantial delay in getting access to new medicines – even after they are approved?

    We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...

    Drug delays

    Read more »